Hypoalbuminemia is significantly associated with increased clearance time of high dose methotrexate in patients being treated for lymphoma or leukemia-Reference-Cited by-同舟云学术

Hypoalbuminemia is significantly associated with increased clearance time of high dose methotrexate in patients being treated for lymphoma or leukemia

Published:2016-08-20 Issue:12 Volume:95 Page:2009-2015
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Reiss Samantha N.^ORCID,Buie Larry W.,Adel Nelly,Goldman Debra A.,Devlin Sean M.,Douer Dan

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-016-2795-7.pdf

Reference20 articles.

1. Jolivet J, Cowan KH, Curt GA et al (1983) The pharmacology and clinical use of methotrexate. N Engl J Med 309:1094–1104

2. Kantarjian HM, O’Brien S, Smith TL et al (2000) Results of treatment with hyper-CVAD, a dose intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol 18(3):547–561

3. Magrath I, Adde M, Venzon D et al (1996) Adults and children with small non-cleaved cell lymphoma have similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol 14:925–934

4. Mead GM, Sydes MR, Walewski J et al (2002) An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt’s lymphoma: results of United Kingdom lymphoma group LY06 study. Ann Oncol 13:1264–1274

5. Yamaguchi M, Kwong YL, Kim WS et al (2011) Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-cell tumor study group study. J Clin Oncol 29:4410–4416

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Potential of Plant-Derived Compounds and Plant Extracts in Rheumatoid Arthritis—Comprehensive Review;Antioxidants;2024-06-27

2. Development of a novel nomogram for predicting delayed methotrexate excretion following high-dose methotrexate in adult patients with hematologic malignancies;Cancer Chemotherapy and Pharmacology;2024-06-21

3. Risk factors associated with high-dose methotrexate induced toxicities;Expert Opinion on Drug Metabolism & Toxicology;2024-03-19

4. Population pharmacokinetic analyses of methotrexate in pediatric patients: a systematic review;European Journal of Clinical Pharmacology;2024-03-18

5. Development of a novel nomogram for predicting delayed methotrexate excretion following high-dose methotrexate in adult patients with hematologic malignancies;2024-02-28